E70.330 Chediak-Higashi syndrome

Name of the Condition

• Chediak-Higashi syndrome (ICD-10-CM Code: E70.330)

Summary

Chediak-Higashi syndrome is a rare genetic disorder characterized by partial albinism, recurrent infections, and a tendency to develop an accelerated phase involving lymphoma-like symptoms. The condition affects multiple body systems, including the immune system, nervous system, and pigmentation.

Causes

Chediak-Higashi syndrome results from mutations in the LYST gene, which disrupts the formation and function of lysosomes. This genetic defect impairs the transport of proteins within cells, leading to abnormal pigment distribution and immune cell dysfunction.

Risk Factors

• Genetic inheritance; typically autosomal recessive, requiring mutations in both copies of the LYST gene.
• Family history of Chediak-Higashi syndrome.
• Higher carrier rates in certain populations for specific genetic variants.

Symptoms

• Partial albinism, including light skin, hair, and eye color.
• Recurrent bacterial infections due to impaired immune function.
• Neurological symptoms such as tremors, poor coordination, and developmental delays.
• An accelerated phase with fever, hepatosplenomegaly, and lymphoma-like symptoms.

Diagnosis

Diagnosis involves a physical exam to assess pigmentation and immune function, blood tests to evaluate white blood cell abnormalities, and genetic testing to confirm LYST gene mutations. Microscopic examination of hair or blood cells may reveal characteristic giant granules.

Treatment Options

Management focuses on symptom control and preventing complications: antibiotics for infections, hematopoietic stem cell transplantation to correct immune defects, and supportive care for neurological symptoms. The accelerated phase may require chemotherapy or immunosuppressive therapy.

Prognosis and Follow-Up

Prognosis depends on the severity of symptoms and response to treatment. Early diagnosis and stem cell transplantation improve outcomes, but the accelerated phase can be life-threatening. Regular follow-up with immunology and hematology specialists is essential to monitor for infections and disease progression.

Complications

• Severe, recurrent infections due to immune system dysfunction.
• Neurological deterioration, including cognitive and motor impairments.
• Development of the accelerated phase, which may lead to organ failure or malignancy.
• Increased risk of bleeding or bruising from platelet abnormalities.

Lifestyle & Prevention

• Avoid exposure to infections by practicing good hygiene and avoiding crowded places.
• Use sunscreen and protective clothing to manage photosensitivity from partial albinism.
• Regular medical check-ups to monitor immune function and detect complications early.
• Genetic counseling for families with a history of the condition.

When to Seek Professional Help

Seek immediate medical attention for signs of severe infection, unexplained fever, or neurological changes. Consult a specialist if recurrent infections or pigmentary changes are observed, as early intervention can improve outcomes.

Tips for Medical Coders

Document the presence of partial albinism, recurrent infections, and any accelerated phase symptoms to support the E70.330 code. Ensure genetic testing results or clinical findings confirming LYST gene mutations are included in the record. Differentiate from other albinism-related codes by noting the specific immune and neurological manifestations.